Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Reviva Pharmaceuticals Holdings (RVPH)
NASDAQ:RVPH
RESEARCH TOOLSreports
Reviva Pharmaceuticals Holdings (RVPH) Stock Price & Analysis
164 Followers
RVPH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.60 - $8.00
Previous Close$1.67
Volume306.92K
Average Volume (3M)277.37K
Market Cap
$46.62M
Enterprise Value$41.87M
Total Cash (Recent Filing)$4.97M
Total Debt (Recent Filing)$222.50K
Price to Earnings (P/E)-1.0
Beta-1.02
Next Earnings
Aug 12, 2024EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.59
Shares Outstanding27,918,560
10 Day Avg. Volume446,979
30 Day Avg. Volume277,367
Standard Deviation0.51
R-Squared0.00027
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-5.60
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.11
Forecast
1Y Price Target
$20.00Price Target Upside1097.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Reviva Pharmaceuticals Holdings News
PremiumCompany Announcements
Reviva Pharmaceuticals Progresses with Global Schizophrenia Trial
PremiumCompany Announcements
Reviva Pharmaceuticals Operational Performance Insights
PremiumCompany Announcements
Reviva Pharmaceuticals Advances Schizophrenia Treatment TrialsOwnership Overview
34.56%
Insiders
4.08% Mutual Funds
10.58% Other Institutional Investors
50.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RVPH FAQ
What was Reviva Pharmaceuticals Holdings’s price range in the past 12 months?
Reviva Pharmaceuticals Holdings lowest stock price was $1.60 and its highest was $8.00 in the past 12 months.
What is Reviva Pharmaceuticals Holdings’s market cap?
Currently, no data Available
When is Reviva Pharmaceuticals Holdings’s upcoming earnings report date?
Reviva Pharmaceuticals Holdings’s upcoming earnings report date is Aug 12, 2024 which is in 86 days.
How were Reviva Pharmaceuticals Holdings’s earnings last quarter?
Currently, no data Available
Is Reviva Pharmaceuticals Holdings overvalued?
According to Wall Street analysts Reviva Pharmaceuticals Holdings’s price is currently Undervalued.
Does Reviva Pharmaceuticals Holdings pay dividends?
Reviva Pharmaceuticals Holdings does not currently pay dividends.
What is Reviva Pharmaceuticals Holdings’s EPS estimate?
Reviva Pharmaceuticals Holdings’s EPS estimate is -$0.34.
How many shares outstanding does Reviva Pharmaceuticals Holdings have?
Reviva Pharmaceuticals Holdings has 27,918,560 shares outstanding.
What happened to Reviva Pharmaceuticals Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Reviva Pharmaceuticals Holdings?
Among the largest hedge funds holding Reviva Pharmaceuticals Holdings’s share is Woodline Partners LP. It holds Reviva Pharmaceuticals Holdings’s shares valued at 4M.
---
Reviva Pharmaceuticals Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.00 (1097.60% Upside)
$20.00 (1097.60% Upside)
Blogger Sentiment
Bullish
RVPH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 934.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 4.0%
Last 30 Days ▲ 4.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-79.07%
12-Months-Change
Fundamentals
Return on Equity
-1806.28%
Trailing 12-Months
Asset Growth
4.61%
Trailing 12-Months
Company Description
Reviva Pharmaceuticals Holdings
Tenzing Acquisition Corp. is a blank check company, which engages in the acquisition of similar business combination with one or more businesses and entities. It focuses on the merger, capital stock exchange, asset acquisition, stock purchase, reorganization, recapitalization, and exchangeable share transaction. The company was founded on March 20, 2018 and is headquartered in New York, NY.
---
RVPH Stock 12 Month Forecast
Average Price Target
$20.00
▲(1097.60% Upside)
Technical Analysis
Puma Biotechnology
―
Corbus Pharmaceuticals
―
vTv Therapeutics
―
Avadel Pharmaceuticals
―
Best Analysts Covering RVPH
1 Year
1 Year Success Rate
2/9 ratings generated profit
1 Year Average Return
+13.99%
reiterated a buy rating 4 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of +13.99% per trade.
---